Below are the financial statements of Gland Pharma, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of INR | 2024 | 2023 |
|---|---|---|
| Income | — | — |
| Revenue from operations | 56,647.22a | 36,246.01a |
| Other income | 1,702.35a | 2,404.63a |
| Total income | 58,349.57a | 38,650.64a |
| Expenses | — | — |
| Cost of materials consumed | -20,221.37a | -17,167.51a |
| Purchase of stock-in-trade | -230.66a | -155.93a |
| Changes in inventories of finished goods, stock-in-trade and work-in-progress | -1,278.85a | -469.17a |
| Power and fuel | -2,299.91a | -1,248.37a |
| Employee benefits expense | -12,568.93a | -4,032.61a |
| Depreciation and amortisation expense | -3,445.66a | -1,467.36a |
| Finance costs | -262a | -74.47a |
| Other expenses | -6,716.77a | -3,863.13a |
| Total expenses | -47,024.15a | -27,540.21a |
| Profit before exceptional item and tax | 11,325.42a | 11,110.43a |
| Exceptional item | 0a | 564.61a |
| Profit before tax | 11,325.42a | 10,545.82a |
| Tax expense | — | — |
| Current tax | -3,492.99a | -2,771.57a |
| Deferred tax charge | -143.34a | -27.99a |
| Taxes of earlier years | -35.51a | -8.19a |
| Total tax expense | -3,600.82a | -2,735.39a |
| Profit for the year | 7,724.6a | 7,810.43a |
| Profit attributable to | — | — |
| Owners of the company | 7,724.6a | 7,810.43a |
| Non-controlling interests | 0a | 0a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Gland Pharma’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.